- Home
- CLH vs ICLR Comparison
CLH vs ICLR Comparison
Compare CLH & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLH
- ICLR
- Stock Information
- Founded
- CLH 1980
- ICLR 1990
- Country
- CLH United States
- ICLR Ireland
- Employees
- CLH N/A
- ICLR N/A
- Industry
- CLH Environmental Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CLH Industrials
- ICLR Health Care
- Exchange
- CLH Nasdaq
- ICLR Nasdaq
- Market Cap
- CLH 12.7B
- ICLR 14.3B
- IPO Year
- CLH 1987
- ICLR 1998
- Fundamental
- Price
- CLH $208.33
- ICLR $166.15
- Analyst Decision
- CLH Buy
- ICLR Buy
- Analyst Count
- CLH 10
- ICLR 15
- Target Price
- CLH $252.90
- ICLR $211.36
- AVG Volume (30 Days)
- CLH 722.5K
- ICLR 984.4K
- Earning Date
- CLH 10-29-2025
- ICLR 10-22-2025
- Dividend Yield
- CLH N/A
- ICLR N/A
- EPS Growth
- CLH N/A
- ICLR N/A
- EPS
- CLH 7.20
- ICLR 7.47
- Revenue
- CLH $5,962,257,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- CLH $2.95
- ICLR N/A
- Revenue Next Year
- CLH $4.16
- ICLR $0.89
- P/E Ratio
- CLH $28.88
- ICLR $21.87
- Revenue Growth
- CLH 2.85
- ICLR N/A
- 52 Week Low
- CLH $178.29
- ICLR $125.10
- 52 Week High
- CLH $264.57
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- CLH 33.36
- ICLR 43.42
- Support Level
- CLH $203.40
- ICLR $155.00
- Resistance Level
- CLH $209.24
- ICLR $167.87
- Average True Range (ATR)
- CLH 6.14
- ICLR 6.44
- MACD
- CLH -1.68
- ICLR -1.26
- Stochastic Oscillator
- CLH 10.84
- ICLR 36.08
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.